Nobetes Corp.

Last Updated:
Federal Trade Commission, Plaintiff, v. Nobetes Corporation, a/k/a Side Effects Solutions Corporation, a corporation; Marvin Silver, individually and as an officer and director of Nobetes Corporation; and Jeffrey Fleitman, individually and as an officer and director of Nobetes Corporation; Defendants.
FTC Matter/File Number:

172 3119

Civil Action Number:

2:18-cv-10068

Enforcement Type:

Federal Injunctions

Federal Court:
Central District of California

Case Summary

In December 2018, officers of a company that marketed and sold Nobetes, a pill they claimed treats diabetes, settled an FTC complaint alleging that the advertising claims for the product are false or unsubstantiated. The order settling the FTC’s complaint prohibits the company and its officers from undertaking future deceptive practices, including making unsubstantiated health claims, misleading consumers about the terms of “free trial” offers, billing consumers without their consent, and other practices related to the use of “expert” endorsements and consumer testimonials. In addition, it requires them to pay money to provide refunds to consumers who bought the product. In August 2019, the FTC returned $60,791 to these consumers.